ResMed Announces Participation in the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum
2022年3月18日 - 05:05AM
ResMed Announces Participation in the KeyBanc Capital Markets' Life
Sciences & MedTech Investor Forum
ResMed (NYSE: RMD, ASX: RMD) today announced Mick Farrell, chief
executive officer, will participate in a virtual fireside chat at
the KeyBanc Capital Markets' Life Sciences & MedTech Investor
Forum on Tuesday, March 22, 2022, beginning at approximately 1:30
p.m. (Eastern Daylight Time) via webcast.
More information about this event, including access to the live
webcast, may be accessed by visiting https://investor.resmed.com.
The webcast replay will be available approximately one hour after
the live webcast ends and will be accessible through June 20,
2022.
About ResMedAt ResMed (NYSE: RMD, ASX: RMD) we
pioneer innovative solutions that treat and keep people out of the
hospital, empowering them to live healthier, higher-quality lives.
Our digital health technologies and cloud-connected medical devices
transform care for people with sleep apnea, COPD, and other chronic
diseases. Our comprehensive out-of-hospital software platforms
support the professionals and caregivers who help people stay
healthy in the home or care setting of their choice. By enabling
better care, we improve quality of life, reduce the impact of
chronic disease, and lower costs for consumers and healthcare
systems in more than 140 countries. To learn more, visit
ResMed.com and follow @ResMed.
For
investors
Amy Wakeham
+1 858.836.5000investorrelations@resmed.comFor
mediaJayme Rubenstein+1 858.836.6798news@resmed.com
Resmed (LSE:0KW4)
過去 株価チャート
から 2 2024 まで 3 2024
Resmed (LSE:0KW4)
過去 株価チャート
から 3 2023 まで 3 2024